Are you an innovator working on a potential solution that may allow us to predict, detect, prevent, or treat emerging infectious diseases? Are you developing science that may help protect vulnerable populations from future health threats?
BLUE KNIGHT™, a joint initiative between Johnson & Johnson Innovation – JLABS (‘JLABS’) and the Biomedical Advanced Research and Development Authority (BARDA), offers emerging life science companies an opportunity to join engage with Johnson & Johnson Innovation by joining the JLABS incubator ecosystem with additional benefits from BARDA. Blue Knight companies are selected for their mutual alignment to the Johnson & Johnson Family of Companies’ and BARDA’s areas of interest.
Opportunities are available at the Blue Knight Hub in JLABS @ Washington, DC, and at various locations across the east coast, including NYC, Boston, and Toronto. Blue Knight companies receive exposure to the full breadth of benefits of the Johnson & Johnson Innovation ecosystem, including third-party services, educational events, access to mentorship from experts across the Johnson & Johnson Family of Companies; and unique benefits for Blue Knight including fee assistance and mentorship from BARDA.
Join us October 25th for a discussion with Blue Knight leadership to learn more about Blue Knight the initiative’s areas of interest, and what the application process entails. We are currently accepting applications.